Open AccessEvaluation of role of alpha-methyl acyl-coenzyme A racemase/P504S and high molecular weight cytokeratin in diagnosing prostatic lesions
Author(s) -
Deepika Jain,
Sumiti Gupta,
Nisha Marwah,
Rajnish Kalra,
Veena Gupta,
Meenu Gill,
Nikita Jain,
Sunder Lal,
Rajeev Sen
Publication year - 2017
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.206239
Subject(s) - medicine , prostate cancer , prostate , cytokeratin , pathology , immunohistochemistry , lesion , cancer
In recent years basal cell markers (high molecular weight cytokeratin [HMWCK]) and prostate biomarker alpha-methyl acyl-coenzyme A racemase (AMACR) have been used as adjuvant to morphology in diagnostically challenging cases with a very high sensitivity and specificity. This has increased the diagnostic accuracy of prostate cancer worldwide.